Buprenorphine vs Durvalumab

Buprenorphine vs Durvalumab: Overview

This comparison examines the pharmacological differences between Buprenorphine and Durvalumab.

Mechanism of Action

Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Buprenorphine — 24-42 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Buprenorphine — C29H41NO4.

Molecular Weight: Buprenorphine — 467.6430 g/mol.

Type: Buprenorphine — Small molecule; Durvalumab — Antibody.